Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Neurology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location

Alzheimer's Disease Clinical Trials

A listing of Alzheimer's Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (533) clinical trials

Over 5 million Americans are living with Alzheimer’s. That means millions of families are learning how to cope with this disease. If you or a loved one has been diagnosed with mild to moderate Alzheimer’s, you may be interested in this research study. Clinical Research Associates in Nashville, TN is ...

Phase

Patient Inclusion Criteria: Ages: over 60 Male/Female 18 week long Clinical Trial Patient may not be full time permanent resident of nursing home Clinical diagnosis of probable AD with supportive brain imaging documentation Have existing neuropsychiatric symptoms as defined by a score equal or greater than 10 on the NPI ...

Phase

Patient Inclusion Criteria: Ages: over 50-90 Male/Female 90 week Long Clinical Trial MMSE score 22-30 Positive amyloid load as indicated by PET assessment Age between 50 and 90 years, inclusive MMSE score equal to or greater than 22, and equal to or less than 30, at Screening and Baseline BMI ...

Phase

Patient Inclusion Criteria: Ages: over 55-90 Male/Female 12 Month Long Clinical Trial MMSE score 24-30/20-26 Subjects must meet criteria for Prodromal AD or Mild AD: Mini Mental State Examination (MMSE) score between 20-30 Clinical Dementia Rating Scale (CDR) score of 0.5 or 1 a free recall score of lesser or ...

Phase

Patient Inclusion Criteria: Ages: over 50-90 Male/Female 12 Month Long Clinical Trial MMSE score 14-20 Adult patients, 50-90 years of age inclusive at time of screening Probable Alzheimer disease, based on the National Institute of Neurological and Communicative Disorders and Stroke (NINCDS)/Alzheimer's Disease and Related Disorders Association (ADRDA) and DSM-IV-TR ...

Phase

Patient Inclusion Criteria: Ages: over 66-85 Male/Female 26 Double Blind Period, Optional 26 week Long Extension No History of Cancer within past 5 years Dementia status of mild to moderate CT or MRI scan within 18 months prior to screening compatible with a diagnosis of probable Alzheimer's disease Score on ...

Phase

Alzheimer's disease is the most common neurodegenerative disorder and its prevalence steeply increases. The small number of effective treatments for Alzheimer's disease highlights a need for further research into novel therapeutic possibilities. Glutamate-mediated excitotoxicity in neuropsychiatric disorders and in particular in Alzheimer's disease has been shown to cause significant cerebral ...

Phase

Do you get lost easily in new places? Do you have a greater tendency to misplace things? Do other people notice that you are forgetful? Have you been diagnosed with Alzheimer's disease? If you are age 60 or over, having memory problems, or already diagnosed with Alzheimer's Disease, currently taking ...

Phase N/A

Consider participating in a clinical research study to evaluate the effectivness and safety of an oral study drug that may help slow the progression of mild to moderate Alzheimer's disease. To participate, you must be 55 to 85 years old with symptoms of mental or functional decline dating back at ...

Phase N/A

This study will evaluate the effects of daily dosing of AC-1204 on cognition, activities of daily living, resource utilization, quality of life, pharmacokinetic measures and safety among participants with mild to moderate Alzheimer's Disease Inclusion Criteria: Dementia status of mild to moderate CT or MRI scan within 18 months prior ...

Phase